Patent ID: 9687540
Date: 2017-06-27
CPC Classifications: A61K,A61P,Y02A

Claim:
1. A trivalent Salmonella vaccine comprising a liquid suspension of formalin-killed, iron-restricted Salmonella enterica serogroup C1 Infantis serovar cells, Salmonella enterica serogroup D Enteritidis serovar cells, and Salmonella enterica serogroup B Typhimurium serovar cells, and an aluminium hydroxide adjuvant; wherein said serogroup C1 serovar cells, said serogroup D serovar cells, and said serogroup B serovar cells all had been grown in an iron-restricted medium that comprised an iron chelator; and wherein when administered to a flock of poultry said trivalent Salmonella vaccine provides protection against a disorder arising from a Salmonella enterica serogroup C2-3 infection.